Haiyan Xu

Haiyan Xu

Auto-generated profile, based on publicly available information

Haiyan Xu

Urology Department, Third Affiliated Hospital of Soochow University, Changzhou 213003, China

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2021 in In Vitro Cellular & Developmental Biology - Animal
Verified
Journal Article
Open access
PDF file
HXHaiyan Xu
Haiyan Xu
DSDan Song
Dan Song
RXRenfang Xu
Renfang Xu
HXHaiyan Xu
Haiyan Xu
Aberrant expression of B cell–activating factor belonging to TNF superfamily (BAFF) and its receptors results in abnormal biological activities in hematopoietic and non-hematopoietic cells and is closely associated with the occurrence and development of various diseases. However, the biological significance and potential mechanisms underlying BAFF signaling in renal tubular epithelial cells (RTECs) remain unknown. This study aimed to investigate the biological role of BAFF signaling in RTECs. Mice primary RTECs were applied. The proliferation status and apoptotic rates were examined by MTS assay and flow cytometry, respectively. The expression of BAFF and its receptors was analyzed via flow cytometry and sodium ion transport function, and cytokeratin-18 expression was detected through immunofluorescence staining. In addition, Pin1 was knocked down via siRNA and its expression was assessed through reverse transcription PCR. Lastly, western blotting was performed to analyze E-cadherin, ɑ-SMA, and Pin1 expression. Results suggested that BAFF-R was significantly upregulated upon IFN-γ stimulation, and enhancement of BAFF signaling promoted cell survival and reduced their apoptotic rate, while simultaneously reducing the epithelial phenotype and promoting the interstitial transformation of cells. Furthermore, Pin1 was significantly increased, along with the upregulation of BAFF signaling in the RTECs, and participated in interstitial transformation induced by BAFF signaling. Collectively, the present results elucidate the potential mechanism of loss of normal function of RTECs under long-term high dose of BAFF stimulation provides a potential therapeutic target for renal interstitial fibrosis, and underlining mechanisms of shortening of long-term outcomes of kidney allografts via augmenting of BAFF signaling.

1 July 2017 in Immunology Letters
Verified
Journal Article
Closed access
HXHaiyan Xu
Haiyan Xu
PDPanpan Dong
Panpan Dong
XMXuyi Ma
Xuyi Ma
DSDan Song
Dan Song
DXDong Xue
Dong Xue
XHXiaozhou He
Xiaozhou He

19 April 2021 in PPAR Research
Verified
Journal Article
Open access
PDF file
RMRuizhe Mao
Ruizhe Mao
JSJian Shi
Jian Shi
XMXuyi Ma
Xuyi Ma
HXHaiyan Xu
Haiyan Xu
Clear cell renal cell carcinoma (ccRCC) is the major pathological pattern of renal cell carcinoma. The ccRCC cells exhibit a certain degree of inherent drug resistance due to some genetic mutations. In recent years, peroxisome proliferator-activated receptor-α (PPARα) antagonists have been reported as a targeted therapeutic drug capable of inducing apoptosis and cell cycle arrest in the ccRCC cell line. Autophagy, which can be induced by stress in eukaryotic cells, plays a complex role in the proliferation, survival, and death of tumor cells. In our study, we found that the expression of PPARα was low in highly differentiated ccRCC tissues and 786-O cell line but high in poorly differentiated ccRCC tissues. The level of PPARα expression in ccRCC tissues is correlated to the grade of differentiation, but not to the sex or age of ccRCC patients. The findings also revealed that the PPARα antagonist GW6471 can lower cell viability and induce autophagy in the 786-O ccRCC cell line. This autophagy can be inhibited by hydroxychloroquine. When treated with a combination of hydroxychloroquine and GW6471, the viability of the 786-O cells was decreased further when compared to the treatment with GW6471 or hydroxychloroquine alone, and apoptosis was promoted. Meanwhile, when human kidney 2 cells were cotreated with hydroxychloroquine and GW6471, cell viability was only slightly influenced. Hence, our finding indicates that the combination of GW6471 and hydroxychloroquine may constitute a novel and potentially effective treatment for ccRCC. Furthermore, this approach is likely to be safe owing to its minimal effects on normal renal tissues.

1 January 2012
Verified
Journal Article
Closed access
HXHaiyan Xu
Haiyan Xu
XHXiaozhou He
Xiaozhou He
WZWei Zhao
Wei Zhao
HGHui Guo
Hui Guo
QSQianqian Shi
Qianqian Shi
XZXueguang Zhang
Xueguang Zhang

1 December 2014
Verified
Journal Article
Closed access
Tao DingTao Ding
Tao Ding
XHXiao-Zhou He
Xiao-Zhou He
XXXian-Lin Xu
Xian-Lin Xu
HXHai-Yan Xu
Hai-Yan Xu
CZCui-Xing Zhou
Cui-Xing Zhou
YWYu-Ji Wang
Yu-Ji Wang

1 November 2016
Verified
Journal Article
Closed access
XMXuyi Ma
Xuyi Ma
XHXiaozhou He
Xiaozhou He
PDPanpan Dong
Panpan Dong
DXDong Xue
Dong Xue
DSDan Song
Dan Song
XZXueguang Zhang
Xueguang Zhang